PL344645A1 - Pth2 receptor selective compounds - Google Patents

Pth2 receptor selective compounds

Info

Publication number
PL344645A1
PL344645A1 PL99344645A PL34464599A PL344645A1 PL 344645 A1 PL344645 A1 PL 344645A1 PL 99344645 A PL99344645 A PL 99344645A PL 34464599 A PL34464599 A PL 34464599A PL 344645 A1 PL344645 A1 PL 344645A1
Authority
PL
Poland
Prior art keywords
selective compounds
receptor selective
abnormal
pth2 receptor
pth2
Prior art date
Application number
PL99344645A
Other languages
English (en)
Inventor
Michael Chorev
Zheng Xin Dong
Michael Rosenblatt
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of PL344645A1 publication Critical patent/PL344645A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL99344645A 1998-05-05 1999-05-03 Pth2 receptor selective compounds PL344645A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7295698A 1998-05-05 1998-05-05

Publications (1)

Publication Number Publication Date
PL344645A1 true PL344645A1 (en) 2001-11-19

Family

ID=22110801

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99344645A PL344645A1 (en) 1998-05-05 1999-05-03 Pth2 receptor selective compounds

Country Status (12)

Country Link
US (2) US7531621B1 (https=)
EP (1) EP1075491B1 (https=)
JP (1) JP4460157B2 (https=)
AT (1) ATE392431T1 (https=)
AU (1) AU3673699A (https=)
CA (1) CA2327509A1 (https=)
DE (1) DE69938548T2 (https=)
ES (1) ES2302374T3 (https=)
HU (1) HUP0300891A2 (https=)
NO (1) NO20005556L (https=)
PL (1) PL344645A1 (https=)
WO (1) WO1999057139A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0962467A4 (en) 1996-09-26 2002-10-30 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
KR100508338B1 (ko) 1997-05-15 2005-08-17 츄가이 세이야꾸 가부시키가이샤 악액질 치료제
WO2001002011A1 (fr) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha REMEDES CONTRE LES MALADIES CAUSEES PAR PTH OU PTHrP
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
US8029793B2 (en) 2000-04-28 2011-10-04 Chugai Seiyaku Kabushiki Kaisha Methods for inhibiting cell proliferation
US20030091973A1 (en) * 2000-09-19 2003-05-15 Horesovsky Gregory J. Method of identifying osteoregenerative agents using differential gene expression
WO2004071396A2 (en) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 2 (pthr2)
BRPI0719885B8 (pt) 2006-10-13 2021-05-25 Lilly Co Eli peptídeos peguilados como moduladores de receptores de pth, seus usos, e composição.
CN104072606B (zh) 2007-08-01 2017-09-22 总医院有限公司 利用g蛋白偶联受体和相关组合物的筛选方法
MX358161B (es) 2010-05-13 2018-08-06 The General Hospital Corp Star Analogos de hormona paratiroidea y usos para los mismos.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001223A (en) * 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
EP0293158A3 (en) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
US5527772A (en) 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
DE68921665T2 (de) 1988-05-09 1995-09-21 Merck & Co Inc Hemmer vom flüssigen kalziumerhöhenden Faktor.
US4968669A (en) 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
US5087562A (en) 1990-04-25 1992-02-11 Merck & Co., Inc. Humoral hypercalcemic factor antagonists with modification at position 13 . . .
US5093233A (en) 1990-04-25 1992-03-03 Merck & Co., Inc. Antagonists with position 13 modification
US5149779A (en) 1990-07-26 1992-09-22 Merck & Co., Inc. Humoral hypercalcemic factor antagonists
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1992011286A1 (en) 1990-12-21 1992-07-09 Allelix Biopharmaceuticals Inc. Oxidation resistant variants of parathyroid hormone
DE4203040A1 (de) 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
US5556940A (en) * 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US5747456A (en) 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5717062A (en) 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
US5969095A (en) 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
JP3259011B2 (ja) * 1995-08-02 2002-02-18 ミヤチテクノス株式会社 インバータ式抵抗溶接制御方法及び装置
JP4142743B2 (ja) 1996-07-31 2008-09-03 ザ・ジェネラル・ホスピタル・コーポレイション 副甲状腺ホルモンに関連する新規ペプチド類似体

Also Published As

Publication number Publication date
US20090226477A1 (en) 2009-09-10
ES2302374T3 (es) 2008-07-01
JP2002513801A (ja) 2002-05-14
WO1999057139A3 (en) 2000-02-03
NO20005556L (no) 2001-01-03
DE69938548D1 (de) 2008-05-29
DE69938548T2 (de) 2009-06-18
CA2327509A1 (en) 1999-11-11
EP1075491A2 (en) 2001-02-14
WO1999057139A2 (en) 1999-11-11
AU3673699A (en) 1999-11-23
HUP0300891A2 (hu) 2003-07-28
JP4460157B2 (ja) 2010-05-12
US7531621B1 (en) 2009-05-12
EP1075491B1 (en) 2008-04-16
NO20005556D0 (no) 2000-11-03
ATE392431T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
PL344645A1 (en) Pth2 receptor selective compounds
AU3652102A (en) Compounds and their uses
JO2359B1 (en) Benzathene derivatives as agents for modulation of GABA A receptor
WO2003105840A3 (en) Sphingosine kinase inhibitors
TNSN04159A1 (fr) Synthese controlee de ziprasidone et compositions en contenant
AU9393601A (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
BG102690A (en) Il-8 receptor antagonists
IL156584A0 (en) Substituted triazole diamine derivatives as kinase inhibitors
MY129293A (en) The use of mmp-13 selective inhibitors for the treatment of osteoarthristis and other mmp-mediated disorders
CA2338256A1 (en) Bioenhanced formulations comprising eprosartan in oral solid dosage form
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
MY117682A (en) Eprosartan dihydrate and a process for its production and formulation
MXPA04002636A (es) Barra de tocador teniendo un acidificador latente.
YU2500A (sh) Alatrofloksacin parenteralni preparati
ZA991922B (en) Novel compositions of eprosartan.
PL337361A1 (en) Chalkones of antiproliferative activity
PL328709A1 (en) Mixture of dehydroepiandrosterone and aromatase inhibiting substances and application of such mixture in production of a therapeutic agent for treating relative and absolute hypoadrogenalaemia among male patients
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
MXPA04003544A (es) Benzotriazepinas como ligandos del receptor de gastrina y colecistocinina.
MY136343A (en) Peptides for treatment of cancer
ZA962176B (en) Use of antioestrogens for controlling male fertility
PL335501A1 (en) Quinoxalinodiones
AU2001262378A1 (en) Method for treating cryptorchidism
TW200506102A (en) Gas feed line structure
WO2004010938A3 (en) Use of chymase inhibitors for the prevention and/or treatment of arterio-venous graft failure

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)